The results of a pilot study suggest that long-term exposure to higher pollen levels leads to worse symptoms and quality of ...
LYON, France--(BUSINESS WIRE)--Regulatory News: PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial ...
A new pilot study known as STAMINA (Senolytics To Alleviate Mobility Issues and Neurological Impairments in Aging), that focused on the effects of senolytic medications, Dasatinib and Quercetin (DQ), ...
First-of-its-Kind European Pilot Study Shows Improvement in Mood, Energy, and Anxiety—Fueling Hope for a New Mental Health Treatment SAN MATEO, Calif.--(BUSINESS WIRE)--Baszucki Group today announced ...
The Community Health Equity Research Institute, with an award from the National Institute on Minority Health and Health Disparities (NIMHD), provides pilot study grants to support projects in health ...